0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Medicine Delivery Devices Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-7A9268
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Subcutaneous Medicine Delivery Devices Market Research Report 2022
BUY CHAPTERS

Global Subcutaneous Medicine Delivery Devices Market Research Report 2025

Code: QYRE-Auto-7A9268
Report
July 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Subcutaneous Medicine Delivery Devices Market

The global market for Subcutaneous Medicine Delivery Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The subcutaneous medicine delivery device is a method, formula, technology and system that transports pharmaceutical compounds into the body at the subcutaneous interface as needed to safely achieve its expected therapeutic effect.
North American market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Subcutaneous Medicine Delivery Devices is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Subcutaneous Medicine Delivery Devices include Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Medicine Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Medicine Delivery Devices.
The Subcutaneous Medicine Delivery Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Medicine Delivery Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Medicine Delivery Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Medicine Delivery Devices Market Report

Report Metric Details
Report Name Subcutaneous Medicine Delivery Devices Market
Segment by Type
  • Implantable Subcutaneous Medicine Delivery Device
  • Injection Type Subcutaneous Medicine Delivery Device
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Zogenix, BD, West Pharmaceutical Services, Ypsomed AG, Elcam Medical, Amgen, Wilhelm Haselmeier
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Medicine Delivery Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Medicine Delivery Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Subcutaneous Medicine Delivery Devices Market report?

Ans: The main players in the Subcutaneous Medicine Delivery Devices Market are Boehringer Ingelheim, Eli Lily, Galaxo, HMD pharmaceuticals, Merck, Novartis, Novo Nordisk, Pfizer, Sanofi, Teva Pharmaceutical, Zogenix, BD, West Pharmaceutical Services, Ypsomed AG, Elcam Medical, Amgen, Wilhelm Haselmeier

What are the Application segmentation covered in the Subcutaneous Medicine Delivery Devices Market report?

Ans: The Applications covered in the Subcutaneous Medicine Delivery Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Subcutaneous Medicine Delivery Devices Market report?

Ans: The Types covered in the Subcutaneous Medicine Delivery Devices Market report are Implantable Subcutaneous Medicine Delivery Device, Injection Type Subcutaneous Medicine Delivery Device

1 Subcutaneous Medicine Delivery Devices Market Overview
1.1 Product Definition
1.2 Subcutaneous Medicine Delivery Devices by Type
1.2.1 Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Implantable Subcutaneous Medicine Delivery Device
1.2.3 Injection Type Subcutaneous Medicine Delivery Device
1.3 Subcutaneous Medicine Delivery Devices by Application
1.3.1 Global Subcutaneous Medicine Delivery Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Medicine Delivery Devices Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Medicine Delivery Devices Revenue 2020-2031
1.4.2 Global Subcutaneous Medicine Delivery Devices Sales 2020-2031
1.4.3 Global Subcutaneous Medicine Delivery Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Medicine Delivery Devices Market Competition by Manufacturers
2.1 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Medicine Delivery Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Medicine Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Date of Enter into This Industry
2.8 Global Subcutaneous Medicine Delivery Devices Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Medicine Delivery Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Medicine Delivery Devices Players Market Share by Revenue
2.8.3 Global Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Medicine Delivery Devices Market Scenario by Region
3.1 Global Subcutaneous Medicine Delivery Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Medicine Delivery Devices Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Medicine Delivery Devices Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Medicine Delivery Devices Sales by Region: 2026-2031
3.3 Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Medicine Delivery Devices Revenue by Region: 2026-2031
3.4 North America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.4.1 North America Subcutaneous Medicine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Medicine Delivery Devices Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Medicine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Medicine Delivery Devices Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Medicine Delivery Devices Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Medicine Delivery Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Medicine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Medicine Delivery Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Medicine Delivery Devices Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Medicine Delivery Devices Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Medicine Delivery Devices Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Medicine Delivery Devices Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Medicine Delivery Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Medicine Delivery Devices Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Medicine Delivery Devices Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Medicine Delivery Devices Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Medicine Delivery Devices Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Medicine Delivery Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Boehringer Ingelheim
6.1.1 Boehringer Ingelheim Company Information
6.1.2 Boehringer Ingelheim Description and Business Overview
6.1.3 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product Portfolio
6.1.5 Boehringer Ingelheim Recent Developments/Updates
6.2 Eli Lily
6.2.1 Eli Lily Company Information
6.2.2 Eli Lily Description and Business Overview
6.2.3 Eli Lily Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Eli Lily Subcutaneous Medicine Delivery Devices Product Portfolio
6.2.5 Eli Lily Recent Developments/Updates
6.3 Galaxo
6.3.1 Galaxo Company Information
6.3.2 Galaxo Description and Business Overview
6.3.3 Galaxo Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Galaxo Subcutaneous Medicine Delivery Devices Product Portfolio
6.3.5 Galaxo Recent Developments/Updates
6.4 HMD pharmaceuticals
6.4.1 HMD pharmaceuticals Company Information
6.4.2 HMD pharmaceuticals Description and Business Overview
6.4.3 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product Portfolio
6.4.5 HMD pharmaceuticals Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Subcutaneous Medicine Delivery Devices Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Company Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Novartis Subcutaneous Medicine Delivery Devices Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Novo Nordisk
6.7.1 Novo Nordisk Company Information
6.7.2 Novo Nordisk Description and Business Overview
6.7.3 Novo Nordisk Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novo Nordisk Subcutaneous Medicine Delivery Devices Product Portfolio
6.7.5 Novo Nordisk Recent Developments/Updates
6.8 Pfizer
6.8.1 Pfizer Company Information
6.8.2 Pfizer Description and Business Overview
6.8.3 Pfizer Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Pfizer Subcutaneous Medicine Delivery Devices Product Portfolio
6.8.5 Pfizer Recent Developments/Updates
6.9 Sanofi
6.9.1 Sanofi Company Information
6.9.2 Sanofi Description and Business Overview
6.9.3 Sanofi Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sanofi Subcutaneous Medicine Delivery Devices Product Portfolio
6.9.5 Sanofi Recent Developments/Updates
6.10 Teva Pharmaceutical
6.10.1 Teva Pharmaceutical Company Information
6.10.2 Teva Pharmaceutical Description and Business Overview
6.10.3 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product Portfolio
6.10.5 Teva Pharmaceutical Recent Developments/Updates
6.11 Zogenix
6.11.1 Zogenix Company Information
6.11.2 Zogenix Description and Business Overview
6.11.3 Zogenix Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Zogenix Subcutaneous Medicine Delivery Devices Product Portfolio
6.11.5 Zogenix Recent Developments/Updates
6.12 BD
6.12.1 BD Company Information
6.12.2 BD Description and Business Overview
6.12.3 BD Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 BD Subcutaneous Medicine Delivery Devices Product Portfolio
6.12.5 BD Recent Developments/Updates
6.13 West Pharmaceutical Services
6.13.1 West Pharmaceutical Services Company Information
6.13.2 West Pharmaceutical Services Description and Business Overview
6.13.3 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.13.4 West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product Portfolio
6.13.5 West Pharmaceutical Services Recent Developments/Updates
6.14 Ypsomed AG
6.14.1 Ypsomed AG Company Information
6.14.2 Ypsomed AG Description and Business Overview
6.14.3 Ypsomed AG Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Ypsomed AG Subcutaneous Medicine Delivery Devices Product Portfolio
6.14.5 Ypsomed AG Recent Developments/Updates
6.15 Elcam Medical
6.15.1 Elcam Medical Company Information
6.15.2 Elcam Medical Description and Business Overview
6.15.3 Elcam Medical Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Elcam Medical Subcutaneous Medicine Delivery Devices Product Portfolio
6.15.5 Elcam Medical Recent Developments/Updates
6.16 Amgen
6.16.1 Amgen Company Information
6.16.2 Amgen Description and Business Overview
6.16.3 Amgen Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.16.4 Amgen Subcutaneous Medicine Delivery Devices Product Portfolio
6.16.5 Amgen Recent Developments/Updates
6.17 Wilhelm Haselmeier
6.17.1 Wilhelm Haselmeier Company Information
6.17.2 Wilhelm Haselmeier Description and Business Overview
6.17.3 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product Portfolio
6.17.5 Wilhelm Haselmeier Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Medicine Delivery Devices Industry Chain Analysis
7.2 Subcutaneous Medicine Delivery Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Medicine Delivery Devices Production Mode & Process Analysis
7.4 Subcutaneous Medicine Delivery Devices Sales and Marketing
7.4.1 Subcutaneous Medicine Delivery Devices Sales Channels
7.4.2 Subcutaneous Medicine Delivery Devices Distributors
7.5 Subcutaneous Medicine Delivery Devices Customer Analysis
8 Subcutaneous Medicine Delivery Devices Market Dynamics
8.1 Subcutaneous Medicine Delivery Devices Industry Trends
8.2 Subcutaneous Medicine Delivery Devices Market Drivers
8.3 Subcutaneous Medicine Delivery Devices Market Challenges
8.4 Subcutaneous Medicine Delivery Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Medicine Delivery Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Medicine Delivery Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Medicine Delivery Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Medicine Delivery Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Medicine Delivery Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Medicine Delivery Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Medicine Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Medicine Delivery Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Medicine Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Medicine Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Medicine Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Medicine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Medicine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Medicine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Medicine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Medicine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Medicine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Medicine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Medicine Delivery Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Medicine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Medicine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Medicine Delivery Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Medicine Delivery Devices Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Medicine Delivery Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Medicine Delivery Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. Boehringer Ingelheim Company Information
 Table 71. Boehringer Ingelheim Description and Business Overview
 Table 72. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. Boehringer Ingelheim Subcutaneous Medicine Delivery Devices Product
 Table 74. Boehringer Ingelheim Recent Developments/Updates
 Table 75. Eli Lily Company Information
 Table 76. Eli Lily Description and Business Overview
 Table 77. Eli Lily Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Eli Lily Subcutaneous Medicine Delivery Devices Product
 Table 79. Eli Lily Recent Developments/Updates
 Table 80. Galaxo Company Information
 Table 81. Galaxo Description and Business Overview
 Table 82. Galaxo Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Galaxo Subcutaneous Medicine Delivery Devices Product
 Table 84. Galaxo Recent Developments/Updates
 Table 85. HMD pharmaceuticals Company Information
 Table 86. HMD pharmaceuticals Description and Business Overview
 Table 87. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. HMD pharmaceuticals Subcutaneous Medicine Delivery Devices Product
 Table 89. HMD pharmaceuticals Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Subcutaneous Medicine Delivery Devices Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Novartis Company Information
 Table 96. Novartis Description and Business Overview
 Table 97. Novartis Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Novartis Subcutaneous Medicine Delivery Devices Product
 Table 99. Novartis Recent Developments/Updates
 Table 100. Novo Nordisk Company Information
 Table 101. Novo Nordisk Description and Business Overview
 Table 102. Novo Nordisk Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Novo Nordisk Subcutaneous Medicine Delivery Devices Product
 Table 104. Novo Nordisk Recent Developments/Updates
 Table 105. Pfizer Company Information
 Table 106. Pfizer Description and Business Overview
 Table 107. Pfizer Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Pfizer Subcutaneous Medicine Delivery Devices Product
 Table 109. Pfizer Recent Developments/Updates
 Table 110. Sanofi Company Information
 Table 111. Sanofi Description and Business Overview
 Table 112. Sanofi Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. Sanofi Subcutaneous Medicine Delivery Devices Product
 Table 114. Sanofi Recent Developments/Updates
 Table 115. Teva Pharmaceutical Company Information
 Table 116. Teva Pharmaceutical Description and Business Overview
 Table 117. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Teva Pharmaceutical Subcutaneous Medicine Delivery Devices Product
 Table 119. Teva Pharmaceutical Recent Developments/Updates
 Table 120. Zogenix Company Information
 Table 121. Zogenix Description and Business Overview
 Table 122. Zogenix Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Zogenix Subcutaneous Medicine Delivery Devices Product
 Table 124. Zogenix Recent Developments/Updates
 Table 125. BD Company Information
 Table 126. BD Description and Business Overview
 Table 127. BD Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. BD Subcutaneous Medicine Delivery Devices Product
 Table 129. BD Recent Developments/Updates
 Table 130. West Pharmaceutical Services Company Information
 Table 131. West Pharmaceutical Services Description and Business Overview
 Table 132. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 133. West Pharmaceutical Services Subcutaneous Medicine Delivery Devices Product
 Table 134. West Pharmaceutical Services Recent Developments/Updates
 Table 135. Ypsomed AG Company Information
 Table 136. Ypsomed AG Description and Business Overview
 Table 137. Ypsomed AG Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 138. Ypsomed AG Subcutaneous Medicine Delivery Devices Product
 Table 139. Ypsomed AG Recent Developments/Updates
 Table 140. Elcam Medical Company Information
 Table 141. Elcam Medical Description and Business Overview
 Table 142. Elcam Medical Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 143. Elcam Medical Subcutaneous Medicine Delivery Devices Product
 Table 144. Elcam Medical Recent Developments/Updates
 Table 145. Amgen Company Information
 Table 146. Amgen Description and Business Overview
 Table 147. Amgen Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 148. Amgen Subcutaneous Medicine Delivery Devices Product
 Table 149. Amgen Recent Developments/Updates
 Table 150. Wilhelm Haselmeier Company Information
 Table 151. Wilhelm Haselmeier Description and Business Overview
 Table 152. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 153. Wilhelm Haselmeier Subcutaneous Medicine Delivery Devices Product
 Table 154. Wilhelm Haselmeier Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Subcutaneous Medicine Delivery Devices Distributors List
 Table 158. Subcutaneous Medicine Delivery Devices Customers List
 Table 159. Subcutaneous Medicine Delivery Devices Market Trends
 Table 160. Subcutaneous Medicine Delivery Devices Market Drivers
 Table 161. Subcutaneous Medicine Delivery Devices Market Challenges
 Table 162. Subcutaneous Medicine Delivery Devices Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Medicine Delivery Devices
 Figure 2. Global Subcutaneous Medicine Delivery Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Medicine Delivery Devices Market Share by Type: 2024 & 2031
 Figure 4. Implantable Subcutaneous Medicine Delivery Device Product Picture
 Figure 5. Injection Type Subcutaneous Medicine Delivery Device Product Picture
 Figure 6. Global Subcutaneous Medicine Delivery Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Subcutaneous Medicine Delivery Devices Market Share by Application: 2024 & 2031
 Figure 8. Hospitals
 Figure 9. Clinics
 Figure 10. Others
 Figure 11. Global Subcutaneous Medicine Delivery Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Subcutaneous Medicine Delivery Devices Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Subcutaneous Medicine Delivery Devices Sales (2020-2031) & (K Units)
 Figure 14. Global Subcutaneous Medicine Delivery Devices Average Price (USD/Unit) & (2020-2031)
 Figure 15. Subcutaneous Medicine Delivery Devices Report Years Considered
 Figure 16. Subcutaneous Medicine Delivery Devices Sales Share by Manufacturers in 2024
 Figure 17. Global Subcutaneous Medicine Delivery Devices Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Subcutaneous Medicine Delivery Devices Players: Market Share by Revenue in Subcutaneous Medicine Delivery Devices in 2024
 Figure 19. Subcutaneous Medicine Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Subcutaneous Medicine Delivery Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 22. North America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 23. United States Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 26. Europe Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Subcutaneous Medicine Delivery Devices Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Subcutaneous Medicine Delivery Devices Revenue Market Share by Region (2020-2031)
 Figure 34. China Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Subcutaneous Medicine Delivery Devices Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Subcutaneous Medicine Delivery Devices Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Subcutaneous Medicine Delivery Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Subcutaneous Medicine Delivery Devices by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Subcutaneous Medicine Delivery Devices by Type (2020-2031)
 Figure 55. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Subcutaneous Medicine Delivery Devices by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Subcutaneous Medicine Delivery Devices by Application (2020-2031)
 Figure 58. Global Subcutaneous Medicine Delivery Devices Price (USD/Unit) by Application (2020-2031)
 Figure 59. Subcutaneous Medicine Delivery Devices Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart